Melphalan With BBBD in Treating Patients With Brain Malignancies

NCT00253721 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped Other competing clinical trials affecting enrollment

Conditions

Brain and Central Nervous System Tumors
Lymphoma
Metastatic Cancer

Interventions

DRUG: Melphalan

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]